Home » Newsletters » BioWorld Asia

BioWorld Asia

April 4, 2001

View Archived Issues

Micromet Raises EUR40M In Fourth Financing Round

Nasdaq Buying Part Of Easdaq In Move That Helps Biotech Firms

Transgene Decides To Refocus, Concentrate On Cancer Programs

Meristem Partners With Goodwin To Gain Foothold In U.S. Market

Alchemia Raises A$15.2M To Expand Research, U.S. Operation

Canada Invests C$21M For Stem Cell Research Initiative

EMEA Sets Out Plans Covering Biotechnology For Next 2 Years

Hybrigenics Launches Map On Protein HIV Interactions

Other News To Note

Oxford Gene, Affymetrix Settle Microarray Patent Litigation

New Group Formed To Assess Drug Competitiveness Issues

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...